
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.120 | 3.150 | 1.030 |
Shares | 99.190 | 100.180 | 0.990 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.022 | 20.118 |
Price to Book | 3.425 | 3.962 |
Price to Sales | 1.676 | 2.393 |
Price to Cash Flow | 13.703 | 16.026 |
Dividend Yield | 0.384 | 1.392 |
5 Years Earnings Growth | 13.709 | 11.874 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 93.390 | 94.831 |
Technology | 5.040 | 2.828 |
Consumer Defensive | 0.960 | 3.308 |
Industrials | 0.620 | 2.529 |
Basic Materials | -0.010 | 1.351 |
Number of long holdings: 145
Number of short holdings: 23
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Invesco NASDAQ Biotech | IE00BQ70R696 | 5.86 | 43.50 | +0.81% | |
Motif Bio PLC | GB00BVVT4H71 | 3.18 | - | - | |
Teladoc Health Inc | - | 2.54 | - | - | |
Eurofins Scientific SE | FR0000038259 | 2.13 | - | - | |
Fagron | BE0003874915 | 2.12 | 20.30 | +1.00% | |
Express Scripts Holding Co | - | 1.91 | - | - | |
Biomarin Pharmaceutical Inc | - | 1.86 | - | - | |
CytoSorbents Corp | - | 1.85 | - | - | |
Hologic Inc | - | 1.75 | - | - | |
Nevro Corp | - | 1.72 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Acatis Gane Value Event Fonds UI A | 6.24B | -0.86 | 4.43 | 5.77 | ||
Acatis Gane Value Event Fonds UI B | 6.24B | -0.74 | 4.86 | 6.21 | ||
Acatis Gane Value Event Fonds UI C | 6.24B | -0.86 | 4.42 | 5.62 | ||
ACATIS Datini Valueflex Fonds A | 697.09M | -9.62 | -3.48 | 9.52 | ||
ACATIS Datini Valueflex Fonds B | 697.09M | -9.83 | -4.29 | 8.71 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review